[SRNE] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -92.89%
YoY- -25.42%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 7,721 6,143 6,246 4,874 988 977 976 41.11%
PBT -68,900 -145,810 -33,574 -25,499 -20,027 -10,616 -10,093 37.69%
Tax -276 -178 -948 -1,696 -1,637 -178 4 -
NP -65,195 -108,071 -32,574 -23,064 -18,390 -10,438 -10,093 36.42%
Tax Rate - - - - - - - -
Total Cost 72,916 114,214 38,820 27,938 19,378 11,415 11,069 36.87%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -844.39 -1,759.25 -521.52 -473.20 -1,861.34 -1,068.37 -1,034.12 -3.31%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.36 -0.88 -0.38 -0.45 -0.48 -0.29 -0.44 -3.28%
EPS Diluted -0.36 -0.88 -0.38 -0.45 -0.48 -0.29 -0.44 -3.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.